28-7 careers

We are working on cutting-edge biology, based on the breakthrough science of our world renowned scientific founders. We are looking for passionate researchers who are as excited as we are about the future of treating human disease. If you are an expert scientist in RNA and/or cancer biology, or on your way to become one, we are interested in hearing from you!


We have an immediate opening for a full-time Scientist / Senior Scientist to join our growing Biology team. This individual will utilize their strong lab-based technical expertise and critical thinking skills to support the company’s primary drug discovery efforts, as well as contribute intellectually to pipeline expansion. We are offering a competitive salary and benefits package for an individual with the following qualifications and experience:


  • Drive biology efforts and support strategic direction for our flagship program

  • Application of cell and molecular biology techniques including, but not limited to, genome editing techniques, qPCR, Western blot, and 2D/3D cell-based phenotypic read-outs

  • Lead the experimental design, execution, and interpretation of results to support preclinical and translational goals

  • Evaluate and implement technologies relevant for our novel area of drug discovery in RNA biology

  • Directly manage contract research organizations (CRO) for outsourced activities

  • Participate in and present results at internal group meetings


  • Ph.D. with 2-5 years, M.S. with 7+ years, or B.S. with 10+ years relevant drug discovery experience in molecular biology or related field

  • Demonstrated scientific rigor in cancer biology and/or RNA-dependent regulatory mechanisms

  • Strong oral and written communication skills, with attention to detail

  • Proven team player among cross-functional disciplines

  • Motivated, independent self-starter comfortable in a dynamic, fast-paced start-up environment

  • Immunology, immune-oncology, and/or bioinformatics experience also a plus

Please send resumes and any other supporting materials to:

Sarah Knutson
Director, Pre-clinical Biology
Twentyeight-Seven Therapeutics